Quarterly report pursuant to Section 13 or 15(d)

Acquisition (Schedule of Pro Forma Results of Operations) (Details)

v3.5.0.2
Acquisition (Schedule of Pro Forma Results of Operations) (Details) - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Business Combinations [Abstract]    
Total revenues $ 191,577 $ 639,944
Net (loss) - Venaxis $ (4,527,483) $ (8,380,348)
Basic and diluted earnings per share $ (1.01) $ (1.86)